|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2003;126:1663-1664
© 2003 The American Association for Thoracic Surgery
Letters to the editor |
a Cardiac Surgical Unit, Harefield Hospital, Middlesex, United Kingdom
To the Editor:
Two articles in your February 2003 issue raise concerns about the Symmetry connector (St Jude Medical, St Paul, Minn) for coronary artery bypass surgery. Hornik and colleagues1 reported 4 of 70 uses and Reuthebuch and colleagues2 reported 7 of 77 uses of Symmetry where severe proximal stenosis occurred. Implicit in both articles is a suggestion that the Symmetry device contributed to proximal graft failures. The observations of Hornik and Reuthebuch, however, cannot be regarded as evidence of such an association for 2 main reasons (neither of which were highlighted in the articles).
As presented, neither report is sufficient to caution against use of the device. Also not considered is the benefit of the technique as it is plausible that morbidity due to aortic calcification or aortic clamping (and by extension the net morbidity and mortality) was reduced by use of the device. Adverse events must be weighed against such benefit, as in at least some cases the benefit of a new technology will outweigh any adverse events. What is required are comparisons between grafts done with Symmetry and those done with standard techniques (preferably with the proximal anastomosis constructed first). Only then can any incremental risk (or benefit) be identified and quantified.
I have never used the Symmetry device and have no special interest in the device or technique; indeed, there may truly be an association between the Symmetry and proximal graft failure. My concern is in the wider area of dissemination and adoption of new technologies. Without statements on data limitations, publication of biased noncomparative data on any new technology is potentially alarmist (or overoptimistic), may prevent proper evaluation and development, and may unnecessarily hinder (or accelerate) uptake of new technologies, some of which could be potentially beneficial (or harmful). Authors of reports on new technologies should list limitations and highlight any confounding factors or alternative explanations for adverse events (or benefits); otherwise readers could be inadvertently misinformed.
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |